MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex)
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Academic Radiology
- Vol. 5, S167-S169
- https://doi.org/10.1016/s1076-6332(98)80095-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (combidex): Preliminary observationsJournal of Magnetic Resonance Imaging, 1997
- Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administrationMagnetic Resonance Imaging, 1994
- AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.Radiology, 1994
- Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.Radiology, 1994
- Phase I clinical evaluation of a new iron oxide MR contrast agentJournal of Magnetic Resonance Imaging, 1994
- MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.American Journal of Roentgenology, 1994
- Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolismMagnetic Resonance Imaging, 1991
- Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.Radiology, 1990
- Hodgkin disease: practical concepts for the diagnostic radiologist.Radiology, 1986
- Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin diseaseAmerican Journal of Roentgenology, 1984